Development and Validation of the iDI: A Short Self-Rating Disability Instrument for Low Back Pain Disorders

Global Spine Journal
Cornelia Rolli SalathéNorbert Boos

Abstract

Cross-sectional and longitudinal validation study. Development and validation of a short, reliable, and valid questionnaire for the assessment of low back pain-related disability. The iDI was created in a stepwise procedure: (1) its development was based on the literature and theoretical consideration; (2) outcome data were collected and evaluated in a pilot study; (3) final validations were performed based on an international multicenter spine surgery outcome study including 514 patients; (4) the iDI was programmed for a tablet computer (iPad) and tested for its clinical practicability. The final version of the iDI comprises of 8 simple questions related to different aspects of disability with a 5-point Likert-type answer scale. The iDI compared very well to the Oswestry Disability Index in terms of reliability and validity. The iDI was demonstrated to be suitable for data assessment on a tablet computer (iPad). The iDI is a short, valid, and practicable tool that facilitates routine quality assessment in terms of low back pain-related disability.

References

Nov 14, 2000·Spine·J C Fairbank, P B Pynsent
Jan 25, 2002·Research in Nursing & Health·Patricia A Patrician
Apr 28, 2005·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·A F MannionJ C T Fairbank
Apr 28, 2005·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·A F MannionD Grob
Jun 7, 2005·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Anne F MannionNorbert Boos
Nov 30, 2005·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Norbert Boos
Dec 2, 2005·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Mathias Haefeli, Achim Elfering
Dec 13, 2006·Journal of Clinical Epidemiology·Caroline B TerweeHenrica C W de Vet
Mar 16, 2007·JAMA : the Journal of the American Medical Association·Michael E Porter, Elizabeth Olmsted Teisberg
Nov 9, 2007·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·M HaefeliN Boos
Mar 7, 2009·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Richard A Deyo, Sohail K Mirza
Jun 6, 2009·The New England Journal of Medicine·Michael E Porter
Jan 13, 2010·British Medical Bulletin·Umile Giuseppe LongoVincenzo Denaro
Feb 11, 2010·Advances in Health Sciences Education : Theory and Practice·Geoff Norman
Dec 24, 2013·Epilepsy & Behavior : E&B·Sallie Baxendale
Jan 27, 2015·Journal of Manipulative and Physiological Therapeutics·Howard Vernon, Gordon Lawson

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Software Mentioned

SPSS
iOS
iDI

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.